Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Novan, Inc. will host its 2023 Annual Meeting of Stockholders on June 6, 2023, in a virtual format. The Chairman, President, and CEO, Paula Brown Stafford, will provide a corporate update after the meeting, including the Company's current focus and plans. The webcast can be accessed at www.virtualshareholdermeeting.com/NOVN2023.
06/05/2023 - 09:00 AM
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6, 2023 at 9:30 a.m. Eastern Time in a virtual format.
The Company also announced that its Chairman, President and CEO, Paula Brown Stafford, will provide a corporate update on the Company after the conclusion of the ASM, including the Company’s current focus, positioning and short and long-term plans, and will host a question-and-answer period.
Guests may listen to the 2023 ASM and the business update by visiting and completing the guest login section of the web portal at www.virtualshareholdermeeting.com/NOVN2023. An archived replay of the webcast will be posted for a limited time following the meeting at that same address. If you are not a stockholder of record, you may still access and listen to the meeting, however, guests will be unable to submit questions during the webcast.
Online check-in will begin 15 minutes prior, at 9:15 a.m. ET. The ASM will begin promptly at 9:30 a.m. ET on June 6, 2023.
About Novan
Novan, Inc. is a medical dermatology company focused on developing and commercializing innovative therapeutic products for skin diseases. Our goal is to deliver safe and efficacious therapies to patients, including developing product candidates where there are unmet medical needs. The U.S. Food and Drug Administration (“FDA”) accepted for filing Novan’s New Drug Application (“NDA”) seeking approval for berdazimer gel, 10.3% (SB206) for the treatment of molluscum contagiosum. The Company also has a pipeline of potential product candidates using its proprietary nitric oxide-based technology platform, NITRICIL™, to generate new treatments for multiple indications.
INVESTOR AND MEDIA CONTACT:
Jenene Thomas
When is Novan, Inc.'s 2023 Annual Meeting of Stockholders?
The meeting will be held on June 6, 2023.
Who will provide a corporate update after the meeting?
Paula Brown Stafford, the Chairman, President, and CEO of Novan, Inc.
Where can I access the webcast of the meeting?
The webcast can be accessed at www.virtualshareholdermeeting.com/NOVN2023.
Can non-stockholders listen to the meeting?
Yes, non-stockholders can listen to the meeting, but they will be unable to submit questions during the webcast.
When does online check-in for the meeting begin?
Online check-in will begin 15 minutes prior to the meeting, at 9:15 a.m. ET.
NOVN Rankings
N/A Ranked by Stock Gains
NOVN Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Morrisville
About NOVN
novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.
